Webinar Test Page
Share |

Webinar Recordings Archive

Top

LaboratoryRegulatoryIndustry

All past webinar recordings are categorized according to the above noted categories. Click one of the headings above to view the webinars listed within that category.

To access webinar slides and audio recordings, please click the title of the desired webinar. Please note ISCT members have free access to slides and audio recordings (6 months after the event).

For more information or assistance, please contact Rony at rony@celltherapysociety.org.


Laboratory

 Webinar TitleOriginal DateSpeakers
 CD34 Enumeration: How and When
 Organized by the Lab Practices Committee
 November 2011

 Frank Prejiers
 Varda Deutsch
 Clean Room Facilities: Cleaning Best Practices
Organized by the Lab Practices Committee
 February 2012

 Richard Meagher
 Andrew Havens
 Facility Size & Challenges in the Lab
 Organized by the Lab Practices Committee
 February 2013 Karl Stasko
 Heather Hansen
 Generation of Antigen-Specific T Cells for Allogeneic Stem Cell Transplant
 Organized by the Australia/New Zealand Regional Executive Committee
 October 2013 Catherine Bollard
 David Gottlieb
 Implementing a New Database
 Organized by the Lab Practices Committee
 September 2009 Richard C. Meagher
 ISBT 128 Labelling for Cellular Therapy
 Organized by the Lab Practices Committee
 February 2009 Chao-Yong Lee
 Giovanna Cameron
 Pat Distler
 ISBT Implementation: What to do and what not to do
 Organized by the Lab Practices Committee
 September 2012 Sara Murray
 Leigh Sims Poston
 Placental Derived Mesenchymal Cells - Isolation, Processing and
 Characterisation

 Organized by the Lab Practices Committee
 September 2011 Ornella Parolini
 Preparing the Lab for a New Clinical Trial
 Organized by the Lab Practices Committee
 November 2013 Todd Schuesler
 Chris Bruns
 Quality Control of Manipulated and Cryopreserved Grafts
 Organized by the Lab Practices Committee
 May 2012 Ulrike Koehl
 Lubomir Arseniev
 Software for Cellular Therapy Facilities
 Organized by the Lab Practices Committee
 April 2011 William Janssen
 Darin Sumstad
 Training/Competency Program for CT Facilities
 Organized by the Lab Practices Committee
 November 2012 Andrew Patmos
 Karen Snow
 Validation and Qualification of Equipment and Reagents (Part I)
 Organized by the Lab Practices Committee
 February 2009 Lizabeth Cardwell
 Karen Edward
 Validation of Processes: Retrospective and Prospective (Part II)
 Organized by the Lab Practices Committee
 March 2009 Elizabeth Konecki
 Olive Sturtevant
 Validation Requirements for Computerized Systems
 Organized by the Lab Practices Committee
 May 2013 Andrew Havens
 Vendor Qualifications
 Organized by the Lab Practices Committee
 February 2011 Deborah Lamontagne
 What's in the Box: Unraveling the Mystery of Cell Therapy
 Organized by the Lab Practices Committee
 February 2014 Karl Stasko
 Lynn O'Donnell

Back to Top

Regulatory

 Webinar TitleOriginal DateSpeakers
 ATMP Regulations
 Organized by the Europe Regional Executive Committee
 June 2013

 Martin Hildebrandt
 Anne Dickinson
 Auditing: Tips, Tools and Techniques
 Organized by the North America Legal & Regulatory Affairs Committee
 June 2009

 J. Wade Atkins

 Batch Records for Cell Therapy Products
 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 William Janssen
 Scott Burger
 Business and Quality Agreements for the Cell Therapy Facility
 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 Karen Edward
 Liz Cardwell
 Distribution Unrelated Manipulated Cord Blood in or to the US after October
 20, 2011: A Domestic and International Perspective

 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 Fran Rabe
 Lisa Philips-Jonson
 Electronic Records: What it Means to be 21CFFR Part 11 Compliant
 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 Karen Nichols
 William Janssen
 Emerging Issues in Cryopreservation
 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 Alison Hubel
 FDA Inspections for Cell Therapy Products from the Perspective of Hospital
 and Industry

 Organized by the North America Legal & Regulatory Affairs Committee
 July 2014 Karen Edward
 Mary Coon
 Elizabeth Konecki
 Generation of Antigen-Specific T Cells for Allogeneic Stem Cell Transplant
 Organized by the Australia/New Zealand Regional Executive Committee
 October 2013

 Catherine Bollard
 David Gottlieb

 GXP Requirements in Translational Research
 Organized by the North America Legal & Regulatory Affairs Committee
 November 2009

 Adrian Gee

 How to Always be Inspection Ready
 Organized by the North America Legal & Regulatory Affairs Committee
 MArch 2013

 J. Olive Sturtevant
 Ed Brindle

 How to Meet GMPs for Phase 1 Trials
 Organized by the North America Legal & Regulatory Affairs Committee
 January 2013

 Deborah Griffin
 Angela Pardee

 Modified T Cells: The implications of their use in the arena of HIV and Cancer
 Organized by the North America Legal & Regulatory Affairs Committee
 March 2011

 Bruce Levine
 Isabelle Riviere

 Potency Assays for Mesenchymal Tissue Regeneration
 Organized by the Europe Regional Executive Committee
 May 2012

 Massimo Dominici
 Wilfried Dalemans

 Potency Testing
 Organized by the North America Legal & Regulatory Affairs Committee
 November 2011

 William Janssen
 Scott Burger

 Practical Guide to INDs/IDEs
 Organized by the North America Legal & Regulatory Affairs Committee
 July 2013

 William Janssen
 Amy Childress

 Risk Management Approach for Cell Therapeutics with Case Studies
 Organized by the North America Legal & Regulatory Affairs Committee
 June 2009

 Asiya Imam
 Olive Sturtevant

 Stability Testing and Optimization
 Organized by the North America Legal & Regulatory Affairs Committee
 September 2009

 Scott Burger
 Aby Mathew

 Sterility Testing for Cellular Therapy Products
 Organized by the Lab Practices Committee
 November 2009

 Federico Rodriquez
 Aisha Khan

 Technological Advances in Contamination Testing
 Organized by the North America Legal & Regulatory Affairs Committee
 November 2013

 Enrique Alvarez
 Russell Marians

 The Circular of Information Basics: What it is and What it is Not
 Organized by the North America Legal & Regulatory Affairs Committee
 June 2012

 Nancy Collins
 Grace Kao

 Transportation of HCT/Ps from UCB, BM and PBSC
 Organized by the North America Legal & Regulatory Affairs Committee
 March 2009

 Karen Nichols
 Lezlie Hynes

Back to Top

Industry

 Webinar TitleOriginal DateSpeakers
 Best Practices in Process Development
 Organized by the Process & Product Development Sub-Committee
 September 2012

 Jon Rowley

 CliniMACS Prodigy: Mastering the Complexity of Cell Processing
 Sponsored by Miltenyi Biotec
 November 2013

 Laurence Cooper
 Mario Assenmacher
 COGs Survey: Results and Red Flags
 Organized by the Business Models & COGs Subcommittee
 November 2013

 William Milligan
 Robert Perry
 Knut Niss
 Developing and Manufacturing Cellular Immunotherapeutics
 Sponsored by Cellerant Therapeutics
 November 2013

 Gautamm Banik
 Generation of Antigen-Specific T Cells for Allogeneic Stem Cell Transplant
 Organized by the Australia/New Zealand Regional Executive Committee
 October 2013

 Catherine Bollard
 David Gottlieb
 hESC Manufacturing
 Organized by the Commercialization Committee
 November 2011

 Ralf Brandenburger
 Steve Oh
 LabSmart Modelling Tool - Operations Modelling to Streamline Cell Therapy Manufacturing
 Organized by the Business Models & COGs Subcommittee
 November 2013

 Maria Chisholm
 Daniel Hopkins
 Novel Methods for Reducing COGs in Autologous Processing
 Organized by the Commercialization Committee
 April 2012

 Juan Vera
 Rosemary Drake
 Potency Testing
 Organized by the Commercialization Committee
 March 2011

 Scott Burger
 Christopher Bravery
 Risk Evaluation Management
 Organized by the Commercialization Committee
 February 2013

 Natalie Mount
 Karin Hoogendoorn
 The Development & Regulation of Cell Therapy Products in Korea
 Organized by the Asia Regional Executive Committee
 March 2014

 Jaesung Kim
 Towards Bioengineered Control of Cell Fate Post Transplantation
 Organized by the Commercialization Committee
 November 2013

 Jeffrey Karp
 Volume reduction technology for large scale harvest or post-thaw manipulation of cellular therapeutics
 Organized by the Commercialization Committee
 February 2012

 Harvey Brandwein
 John Chapman

Back to Top

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.